Isobutonitazene
| Isobutonitazene | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 424.50 g/mol [1] |
| Predicted LogP | 5.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C24H32N4O3 |
| IUPAC name | N,N-diethyl-2-[2-[[4-(2-methylpropoxy)phenyl]methyl]-5-nitrobenzimidazol-1-yl]ethanamine |
| SMILES | CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCC(C)C |
| InChI | InChI=1S/C24H32N4O3/c1-5-26(6-2)13-14-27-23-12-9-20(28(29)30)16-22(23)25-24(27)15-19-7-10-21(11-8-19)31-17-18(3)4/h7-12,16,18H,5-6,13-15,17H2,1-4H3 |
| InChIKey | KQZNQVXEZPNJQC-UHFFFAOYSA-N |
| PubChem CID | 168322282 |
Isobutonitazene (also known as iso-Butonitazene (citrate) or iso-Butonitazene) is a opioid substance of the aniline and nitazene class.
Chemistry
Stereochemistry []
Isobutonitazene is achiral.
Druglikeness
Lipinski's rule of five
Isobutonitazene matches Lipinski's rule of five (violations: 1).Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 168322282, Isobutonitazene. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/168322282
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 17:00:44 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 17:00:40 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 17:00:40 |
| gsrs | missing (no UNII) | 2026-11-20 17:00:40 |
| hmdb | missing (no HMDB id) | 2026-11-20 17:00:40 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 17:00:42 |
| pubchem | ok | 2026-11-20 17:00:39 |
| missing (no r/tripreports posts mention it) | 2026-11-20 17:00:40 | |
| sider | missing (not in SIDER) | 2026-11-20 17:00:40 |
| structure | ok | 2026-11-20 17:00:40 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 17:00:40 |